← Back to patent-cliff list
Colesevelam Hydrochloride
Tier C — Watch / tradeColesevelam Hydrochloride
Genzyme Corporation
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：I-BABP
Brand：Colestagel, Welchol, CholestaGel
Indications (approved)：Hypercholesterolaemia, Hyperlipoproteinaemia type II, Type 2 diabetes, Hyperlipidaemia
Regional status
US
Approved
2000-05-26
EU
Approved
2004-03-09
China
Filed / under review
2022-10-18
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Colesevelam Hydrochloride?
Approved indications include: Hypercholesterolaemia, Hyperlipoproteinaemia type II, Type 2 diabetes, Hyperlipidaemia.
When does the Colesevelam Hydrochloride patent expire?
No public expiry year is available for Colesevelam Hydrochloride yet; this page updates once verified.
How do I get a quote for Colesevelam Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27